Urteste (WSE:URT) Is In A Good Position To Deliver On Growth Plans
Jul 19
Polish (WIG) Biotech Industry Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies12
- 7D0.1%
- 3M-1.6%
- 1Y-15.6%
- YTD-9.9%
Last week, the Biotech industry hasn't moved much but Pure Biologics is up 58% in that time. As for the longer term, the industry has declined 16% in the last year.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | zł2.1b | zł444.2m | -zł64,230,755.00 | 73.5x | -33.1x | 4.8x |
| Sun, 23 Jun 2024 | zł2.1b | zł444.3m | -zł95,946,755.00 | 71x | -21.7x | 4.7x |
| Tue, 21 May 2024 | zł2.3b | zł438.3m | -zł94,485,228.00 | 71x | -23.9x | 5.2x |
| Thu, 18 Apr 2024 | zł2.3b | zł437.8m | -zł72,667,007.00 | 52.6x | -31.5x | 5.2x |
| Sat, 16 Mar 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 61.6x | -30.5x | 4.9x |
| Mon, 12 Feb 2024 | zł2.4b | zł459.9m | -zł74,255,671.00 | 123.7x | -31.9x | 5.1x |
| Wed, 10 Jan 2024 | zł2.8b | zł499.9m | -zł66,755,911.00 | 90.8x | -41.8x | 5.6x |
| Fri, 08 Dec 2023 | zł2.7b | zł499.9m | -zł66,755,911.00 | 89.1x | -39.8x | 5.3x |
| Sun, 05 Nov 2023 | zł2.7b | zł511.7m | -zł63,340,678.00 | 46x | -42.4x | 5.2x |
| Tue, 03 Oct 2023 | zł2.7b | zł518.4m | -zł60,858,678.00 | 48.2x | -44.4x | 5.2x |
| Thu, 31 Aug 2023 | zł2.8b | zł520.3m | -zł43,292,668.00 | 49.5x | -64.6x | 5.4x |
| Sat, 29 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 52.9x | -68x | 5.5x |
| Mon, 26 Jun 2023 | zł2.9b | zł520.7m | -zł41,322,721.00 | 54.1x | -69.7x | 5.5x |
| Wed, 24 May 2023 | zł2.9b | zł520.8m | -zł43,534,021.00 | 68.6x | -67.6x | 5.6x |
| Fri, 21 Apr 2023 | zł2.9b | zł528.2m | -zł13,228,449.00 | 65.5x | -216.5x | 5.4x |
| Sun, 19 Mar 2023 | zł2.7b | zł488.6m | -zł16,165,349.00 | 59.9x | -168.3x | 5.6x |
| Tue, 14 Feb 2023 | zł2.9b | zł485.6m | -zł15,920,441.00 | 60.4x | -184x | 6x |
| Thu, 12 Jan 2023 | zł2.9b | zł496.5m | -zł10,783,764.00 | 49.2x | -270.6x | 5.9x |
| Sat, 10 Dec 2022 | zł2.8b | zł496.5m | -zł10,783,764.00 | 46.3x | -255x | 5.5x |
| Mon, 07 Nov 2022 | zł2.7b | zł453.7m | -zł20,019,868.00 | 45.9x | -132.8x | 5.9x |
| Wed, 05 Oct 2022 | zł2.5b | zł444.0m | -zł13,473,868.00 | 57.4x | -187x | 5.7x |
| Fri, 02 Sep 2022 | zł2.7b | zł390.2m | -zł7,043,258.00 | 60.9x | -384.7x | 6.9x |
| Sun, 31 Jul 2022 | zł2.7b | zł472.9m | zł66,686.00 | 27.7x | 40961.2x | 5.8x |
| Tue, 28 Jun 2022 | zł2.3b | zł472.9m | zł66,686.00 | 24.9x | 34159.9x | 4.8x |
| Thu, 26 May 2022 | zł2.5b | zł426.5m | zł14.0m | 35x | 175.3x | 5.8x |
| Sat, 23 Apr 2022 | zł2.8b | zł369.1m | -zł37,778,677.00 | 36.1x | -72.8x | 7.5x |
| Mon, 21 Mar 2022 | zł2.8b | zł348.8m | -zł40,884,677.00 | 33.1x | -68.6x | 8x |
| Wed, 16 Feb 2022 | zł3.1b | zł348.5m | -zł40,520,361.00 | 51.5x | -76.7x | 8.9x |
| Fri, 14 Jan 2022 | zł3.7b | zł369.9m | -zł24,922,742.00 | 49.5x | -147.5x | 9.9x |
| Sun, 12 Dec 2021 | zł3.7b | zł369.9m | -zł24,922,742.00 | 49.8x | -149.9x | 10.1x |
| Tue, 09 Nov 2021 | zł3.6b | zł368.8m | zł763.7k | 32.8x | 4687.4x | 9.7x |
| Thu, 07 Oct 2021 | zł3.5b | zł364.5m | -zł1,455,285.00 | 33.3x | -2377.6x | 9.5x |
| Sat, 04 Sep 2021 | zł3.7b | zł362.9m | -zł8,912,285.00 | 38.8x | -411.8x | 10.1x |
| Mon, 02 Aug 2021 | zł3.6b | zł362.9m | -zł8,912,285.00 | 37.4x | -400.2x | 9.8x |
Price to Earnings Ratio
-400.2x
Current Industry PE
- Investors are pessimistic on the Polish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 6.5x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 7.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -2.84% | |
| Healthcare | 0.31% | |
| Biotech | 0.11% | |
| Biotech | 0.11% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PUR Pure Biologics | zł26.65 | 57.7% +zł32.4m | 61.3% | PS1285.3x | |
| PTG Poltreg | zł52.80 | 7.5% +zł17.3m | -12.0% | PS273.6x | |
| URT Urteste | zł105.00 | 10.5% +zł14.1m | -4.5% | PS150.9x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł79.00 | 3.4% +zł12.1m | -43.2% | PS22.8x | |
| MAB Mabion | zł17.54 | 2.9% +zł8.1m | -0.6% | PE6.7x |
